BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16680230)

  • 1. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
    Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
    Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin.
    Saeian K; Bajaj JS; Franco J; Knox JF; Daniel J; Peine C; McKee D; Varma RR; Ho S;
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1189-93. PubMed ID: 15569122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].
    Niederau C; Bemba G; Kautz A
    Z Gastroenterol; 2008 Jan; 46(1):22-33. PubMed ID: 18188813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
    John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
    Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.
    Honda T; Katano Y; Urano F; Murayama M; Hayashi K; Ishigami M; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
    J Gastroenterol Hepatol; 2007 Jul; 22(7):989-95. PubMed ID: 17608843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C.
    Becquemont L; Chazouilleres O; Serfaty L; Poirier JM; Broly F; Jaillon P; Poupon R; Funck-Brentano C
    Clin Pharmacol Ther; 2002 Jun; 71(6):488-95. PubMed ID: 12087352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The adherence in the treatment of chronic hepatitis C].
    Pawłowska M; Halota W
    Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with chronic hepatitis C with normal liver enzymes.
    Akbar HO
    Saudi Med J; 2002 Mar; 23(3):301-4. PubMed ID: 11938421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in "real life"].
    Pariente A; Djilloul A; Cadranel JF;
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):590-5. PubMed ID: 12910222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
    Raison CL; Woolwine BJ; Demetrashvili MF; Borisov AS; Weinreib R; Staab JP; Zajecka JM; Bruno CJ; Henderson MA; Reinus JF; Evans DL; Asnis GM; Miller AH
    Aliment Pharmacol Ther; 2007 May; 25(10):1163-74. PubMed ID: 17451562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
    Yu ML; Dai CY; Lee LP; Hou NJ; Hsieh MY; Huang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    Liver Int; 2006 Dec; 26(10):1187-95. PubMed ID: 17105583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.
    Fontana RJ; Moyer CA; Sonnad S; Lok ASF ; Sneed-Pee N; Walsh J; Klein S; Webster S
    Am J Gastroenterol; 2001 Jan; 96(1):170-8. PubMed ID: 11197249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C.
    Shakoor A; Shafqat F; Mehmud Te; Akram M; Riaz S; Iqbal Z; Khan AA
    J Ayub Med Coll Abbottabad; 2010; 22(4):6-9. PubMed ID: 22455250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.